Modified Inhaled Nitric Oxide in Ventilated Patients With Acute Respiratory Failure
Key facts
- Who runs it
- Southeast University, China
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 424 people, planned
- Started
- 1 Nov 2026
- Expected to end
- 20 Feb 2029
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Modified iNO
- Record updated
- 27 October 2026
Who can take part
- Age
- 18 years to 90 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Age ≥ 18 years
- Acute respiratory failure (PaO₂/FiO₂ ratio < 300 mmHg)
- Endotracheal intubation due to pneumonia
- Duration of mechanical ventilation ≤ 72 h
Who cannot take part
- Patients who received iNO or ECMO prior to enrollment
- Severe chronic respiratory disease requiring long-term home oxygen therapy or noninvasive ventilation
- History of pulmonary malignancy, pneumonectomy, or lung transplantation
- Expected duration of mechanical ventilation < 48 h
- Severe other organs dysfunction with a low expected survival (7 days) or palliative care
- Pregnancy or lactation
- Refusal to sign the informed consent
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Acute respiratory failure or nitric oxide or pneumonia
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pneumonia is the main cause of ICU admission in patients with acute respiratory failure (ARF). Severe pneumonia is a serious lung infection caused by bacteria, fungi, viruses, and other pathogens. It often leads to respiratory failure requiring mechanical ventilation. It is also accompanied by septic shock or multiple organ dysfunction, and patients need intensive care. The average mortality rate is 30%-40%. Therefore, there is an urgent need to find treatments that improve outcomes in patients with severe pneumonia. Inhaled nitric oxide (iNO) can selectively dilate pulmonary vessels in well-ventilated lung areas. This reduces pulmonary artery pressure, improves the ventilation/perfusion ratio, and increases oxygenation. At 80 ppm, iNO can effectively reduce mean pulmonary artery pressure and pulmonary vascular resistance. It also reduces oxidative stress and has anti-inflammatory effects. Short-term inhalation is safe. The level of positive end-expiratory pressure (PEEP) affects the effect of NO. Setting PEEP according to airway opening pressure (AOP) can deliver iNO efficiently to target areas. Based on this, the study team designed this randomized controlled trial to investigate whether a modified iNO regimen, PEEP set according to AOP combined with 80 ppm NO, improves outcomes in patients with acute respiratory failure receiving mechanical ventilation.
The 2 groups in the trial
- Modified iNO groupTreatment being tested
Patients will receive PEEP set according to AOP and undergo an iNO trial with an initial concentration of 80 ppm and subsequent stepwise reduction.
Treatment: Modified iNO
- Low PEEP-FiO2 table groupNo study treatment, for comparison
PEEP will be set according to the low FiO2-PEEP table.
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of a Modified Inhaled Nitric Oxide Regimen on Outcomes in Patients With Acute Respiratory Failure Receiving Mechanical Ventilation: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial
- Criteria questions
- Built from NCT07892001, who can take part
- Record updated
- 27 October 2026